Novel EEG Coherence Biomarkers for PTSD Assessment
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Bedford, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 26 people enrolled
- Started
- 1 Feb 2021
- Ended
- 31 Dec 2024
- Type of study
- Observational
- Treatments tested
- Acceptance and Commitment Therapy to Improve Social Support for Veterans with PTSD ( ACT-SS)
- Record updated
- 25 November 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- Veterans who have been previously deployed and meet diagnostic criteria for PTSD. Prior traumatic experience(s) does not have to be direct combat (e.g. may include search and rescue of combat operations). Persons previously treated for PTSD will be eligible so long as current diagnostic criteria are present. Specific inclusion criteria are as follows:; Current (past month) diagnosis of PTSD as determined from the 30-item CAPS (score >45); History of deployment and combat-related exposure stated as the principal reason for seeking treatment (based on self-report); Ability to read and speak English to complete surveys and participate in therapy; Explicit denial of suicidal or homicidal ideation or intent, which will be corroborated by reviewing the patient chart
Who cannot take part
- Major confounding psychiatric disorder; i.e. assessment indicates presence of:; Major mental health disorder that involves psychosis; Otherwise in the state of psychological crisis (appropriate referral to occur); Current or recent (within 1 month of study entry) DSM-5 substance use disorder; Individuals who are taking either illicit or prescribed Rx that could interfere with EEG, including benzodiazepines and certain mood stabilizers (e.g., Lithium)
- Brain injury prohibiting speech, writing, and purposeful actions
- Identified to have current suicidal or homicidal ideation (immediate referral to a crisis center/hospital)
Where in United States
- VA Bedford HealthCare System, Bedford, MABedford, United States
About the trial
What the trial wants to find out
Current practice for diagnosing and managing PTSD relies primarily on subjective clinical assessments by clinicians as well as patient self-report. An independent, objective and neuro-physiology based method for directly assessing brain function is not available, but is much needed to improve diagnosis and management of PTSD. To address this critical need, the investigators propose to test a set of novel biomarkers which are based on measures of coherent activity among the regions of cerebral cortex during sleep. In preliminary studies on EEG acquired during sleep from Veterans with PTSD alone as well as other co-morbidities, the investigators have shown that the neuromarkers were highly sensitive/specific to the presence of PTSD, and highly sensitive to the severity of symptoms in PTSD group. The overall goal of this project is to further validate these novel neurophysiology marker in retrospective and prospective studies
The group in the trial
- PTSD Undergoing Psycho-therapy
Veterans with PTSD seeking treatment and undergoing psycho-therapy
Treatment: Acceptance and Commitment Therapy to Improve Social Support for Veterans with PTSD ( ACT-SS)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Neurophysiology Markers of PTSD's Presence, Severity and Therapy Outcome
- Record updated
- 25 November 2025